Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives.

Monguió-Tortajada, Marta; Bayes-Genis, Antoni; Rosell, Antoni; Roura, Santiago

Monguió-Tortajada, Marta; Bayes-Genis, Antoni; Rosell, Antoni; Roura, Santiago.

Monguió-Tortajada M; ICREC Research Program, Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona, Catalunya, Spain.
Bayes-Genis A; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.
Rosell A; ICREC Research Program, Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona, Catalunya, Spain.
Roura S; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.

Thorax ; 76(2): 196-200, 2021 02.

Article in English | MEDLINE | ID: covidwho-978829

Subject(s)

COVID-19/pathology; Extracellular Vesicles; Inflammation/pathology; Mesenchymal Stem Cells/cytology; COVID-19/epidemiology; Humans; SARS-CoV-2

Keywords

ARDS; cytokine biology; pneumonia; respiratory infection; viral infection

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mesenchymal Stem Cells / Extracellular Vesicles / COVID-19 / Inflammation Type of study: Observational study Limits: Humans Language: English Journal: Thorax Year: 2021 Document Type: Article Affiliation country: Thoraxjnl-2020-215717

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google